glp-1 gip vs tirzepatide Effects of tirzepatide, a dual and receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Tirzepatide 10mg — GLP-1/GIP Dual-Agonist

Do not escalate sooner unless directed by your healthcare provider

The medication occupies both receptors simultaneously to suppress appetite and regulate blood glucose levels

Nausea affects 40% to 45% of people at higher doses, diarrhea occurs in 30% to 35%, constipation affects 20% to 25%, vomiting happens in 10% to 15%, and abdominal discomfort occurs in 20% to 30%

Critically, apoptosis was significantly induced in MC38 cells, as confirmed via Annexin V/PI flow cytometry and TUNEL assays, with the effects being independent of extracellular glucose levels (2 mM vs

Persistent diarrhea beyond 2-3 weeks is less common and warrants clinical evaluation

This dual nature makes it prone to forming aggregates, clusters of peptide molecules that clump together in solution